JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients

Pabitra Basnyat; Elina Virtanen; Irina Elovaara; Sanna Hagman; Eeva Auvinen

doi:10.1007/s13365-017-0560-x

JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients

Pabitra Basnyat, Elina Virtanen, Irina Elovaara, Sanna Hagman, Eeva Auvinen

Department of Neurosciences and Rehabilitation

Research output: Contribution to journal › Article › Scientific › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	734-41
Journal	Journal of NeuroVirology
Volume	23
Issue number	5
DOIs	https://doi.org/10.1007/s13365-017-0560-x
Publication status	Published - 2017
Publication type	A1 Journal article-refereed

Keywords

Anti-JCPyV antibody index
Biomarker
IFN-?
JCPyV miRNA
Multiple sclerosis
Natalizumab PML

Publication forum classification

Publication forum level 1

Access to Document

10.1007/s13365-017-0560-x

Cite this

@article{c236b1aaba10494cad1677ea0eee4bc7,

title = "JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients",

keywords = "Anti-JCPyV antibody index, Biomarker, IFN-?, JCPyV miRNA, Multiple sclerosis, Natalizumab PML, Anti-JCPyV antibody index, Biomarker, IFN-?, JCPyV miRNA, Multiple sclerosis, Natalizumab PML",

author = "Pabitra Basnyat and Elina Virtanen and Irina Elovaara and Sanna Hagman and Eeva Auvinen",

year = "2017",

doi = "10.1007/s13365-017-0560-x",

language = "English",

volume = "23",

pages = "734--41",

number = "5",

}

TY - JOUR

T1 - JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients

AU - Basnyat, Pabitra

AU - Virtanen, Elina

AU - Elovaara, Irina

AU - Hagman, Sanna

AU - Auvinen, Eeva

PY - 2017

Y1 - 2017

KW - Anti-JCPyV antibody index

KW - Biomarker

KW - IFN-?

KW - JCPyV miRNA

KW - Multiple sclerosis

KW - Natalizumab PML

KW - Anti-JCPyV antibody index

KW - Biomarker

KW - IFN-?

KW - JCPyV miRNA

KW - Multiple sclerosis

KW - Natalizumab PML

U2 - 10.1007/s13365-017-0560-x

DO - 10.1007/s13365-017-0560-x

M3 - Article

VL - 23

SP - 734

EP - 741

IS - 5

ER -